As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa/Asia
Shares of Panacea Biotec surged up to 4.48 per cent at Rs 319.40 on the BSE in Friday's intraday trade
The shares of Panacea Biotec rose after the company announced that it has secured $20 million in loan from US International Development Finance Corp (DFC).
A combined 2.1 million equity shares of the company had changed hands till 02:50 PM, and there are pending buy orders for nearly 100,000 shares on the NSE and BSE.